Copyright Reports & Markets. All rights reserved.

Global Transcatheter Aortic Valve Replacement (TAVR) Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Transcatheter Aortic Valve Replacement (TAVR) by Type
    • 1.3.1 Overview: Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Consumption Value Market Share by Type in 2024
    • 1.3.3 Transfemoral Approach
    • 1.3.4 Transapical Approach
    • 1.3.5 Others
  • 1.4 Global Transcatheter Aortic Valve Replacement (TAVR) Market by Application
    • 1.4.1 Overview: Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Aortic Stenosis
    • 1.4.3 Aortic Regurgitation
    • 1.4.4 Others
  • 1.5 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size & Forecast
  • 1.6 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast by Region
    • 1.6.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region, (2020-2031)
    • 1.6.3 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size and Prospect (2020-2031)
    • 1.6.6 South America Transcatheter Aortic Valve Replacement (TAVR) Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Edwards Lifesciences
    • 2.1.1 Edwards Lifesciences Details
    • 2.1.2 Edwards Lifesciences Major Business
    • 2.1.3 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Product and Solutions
    • 2.1.4 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Edwards Lifesciences Recent Developments and Future Plans
  • 2.2 Medtronic
    • 2.2.1 Medtronic Details
    • 2.2.2 Medtronic Major Business
    • 2.2.3 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Product and Solutions
    • 2.2.4 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Medtronic Recent Developments and Future Plans
  • 2.3 Abbott
    • 2.3.1 Abbott Details
    • 2.3.2 Abbott Major Business
    • 2.3.3 Abbott Transcatheter Aortic Valve Replacement (TAVR) Product and Solutions
    • 2.3.4 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Abbott Recent Developments and Future Plans
  • 2.4 Boston Scientific
    • 2.4.1 Boston Scientific Details
    • 2.4.2 Boston Scientific Major Business
    • 2.4.3 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Product and Solutions
    • 2.4.4 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Boston Scientific Recent Developments and Future Plans
  • 2.5 Meril Life Sciences
    • 2.5.1 Meril Life Sciences Details
    • 2.5.2 Meril Life Sciences Major Business
    • 2.5.3 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Product and Solutions
    • 2.5.4 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Meril Life Sciences Recent Developments and Future Plans
  • 2.6 Venus Medtech
    • 2.6.1 Venus Medtech Details
    • 2.6.2 Venus Medtech Major Business
    • 2.6.3 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Product and Solutions
    • 2.6.4 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Venus Medtech Recent Developments and Future Plans
  • 2.7 Bracco (HLT)
    • 2.7.1 Bracco (HLT) Details
    • 2.7.2 Bracco (HLT) Major Business
    • 2.7.3 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Product and Solutions
    • 2.7.4 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Bracco (HLT) Recent Developments and Future Plans
  • 2.8 JenaValve Technology
    • 2.8.1 JenaValve Technology Details
    • 2.8.2 JenaValve Technology Major Business
    • 2.8.3 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Product and Solutions
    • 2.8.4 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 JenaValve Technology Recent Developments and Future Plans
  • 2.9 Suzhou Jiecheng Medical Technology Co.
    • 2.9.1 Suzhou Jiecheng Medical Technology Co. Details
    • 2.9.2 Suzhou Jiecheng Medical Technology Co. Major Business
    • 2.9.3 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Product and Solutions
    • 2.9.4 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Suzhou Jiecheng Medical Technology Co. Recent Developments and Future Plans
  • 2.10 Peijia Medical
    • 2.10.1 Peijia Medical Details
    • 2.10.2 Peijia Medical Major Business
    • 2.10.3 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Product and Solutions
    • 2.10.4 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Peijia Medical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Transcatheter Aortic Valve Replacement (TAVR) by Company Revenue
    • 3.2.2 Top 3 Transcatheter Aortic Valve Replacement (TAVR) Players Market Share in 2024
    • 3.2.3 Top 6 Transcatheter Aortic Valve Replacement (TAVR) Players Market Share in 2024
  • 3.3 Transcatheter Aortic Valve Replacement (TAVR) Market: Overall Company Footprint Analysis
    • 3.3.1 Transcatheter Aortic Valve Replacement (TAVR) Market: Region Footprint
    • 3.3.2 Transcatheter Aortic Valve Replacement (TAVR) Market: Company Product Type Footprint
    • 3.3.3 Transcatheter Aortic Valve Replacement (TAVR) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Transcatheter Aortic Valve Replacement (TAVR) Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Transcatheter Aortic Valve Replacement (TAVR) Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Type (2020-2031)
  • 6.2 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application (2020-2031)
  • 6.3 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country
    • 6.3.1 North America Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Country (2020-2031)
    • 6.3.2 United States Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Type (2020-2031)
  • 7.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Application (2020-2031)
  • 7.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country
    • 7.3.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 7.3.3 France Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region
    • 8.3.1 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Region (2020-2031)
    • 8.3.2 China Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 8.3.5 India Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Type (2020-2031)
  • 9.2 South America Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Application (2020-2031)
  • 9.3 South America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country
    • 9.3.1 South America Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country
    • 10.3.1 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Transcatheter Aortic Valve Replacement (TAVR) Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Transcatheter Aortic Valve Replacement (TAVR) Market Drivers
  • 11.2 Transcatheter Aortic Valve Replacement (TAVR) Market Restraints
  • 11.3 Transcatheter Aortic Valve Replacement (TAVR) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Chain
  • 12.2 Transcatheter Aortic Valve Replacement (TAVR) Upstream Analysis
  • 12.3 Transcatheter Aortic Valve Replacement (TAVR) Midstream Analysis
  • 12.4 Transcatheter Aortic Valve Replacement (TAVR) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Transcatheter Aortic Valve Replacement (TAVR) market size was valued at US$ 9024 million in 2024 and is forecast to a readjusted size of USD 18060 million by 2031 with a CAGR of 10.5% during review period.
    Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
    The Transcatheter Aortic Valve Replacement (TAVR) market is primarily driven by the increasing prevalence of aortic stenosis and the growing aging population worldwide. As people live longer, the incidence of age-related cardiovascular conditions, such as aortic valve disease, is on the rise. TAVR offers a minimally invasive alternative to traditional open-heart surgery, making it a highly attractive option for elderly patients or those with high surgical risk. Additionally, technological advancements in TAVR devices, such as improved valve designs, delivery systems, and procedural techniques, have contributed to enhanced patient outcomes and safety, further expanding the market. The increasing acceptance of TAVR as a first-line treatment, even for intermediate-risk patients, also fuels market growth.
    However, the TAVR market faces several challenges, primarily the high cost of the procedure and devices. Despite its advantages, TAVR is still a relatively expensive treatment, which can limit its accessibility, particularly in low- and middle-income countries or healthcare systems with constrained budgets. Furthermore, the long-term durability of TAVR valves remains a concern for both physicians and patients, as the procedure is relatively new compared to traditional surgical valve replacements. Ongoing research and clinical trials are needed to better understand the long-term outcomes of TAVR, which could influence its adoption and cost-effectiveness in the future.
    Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, etc. are the leaders of the industry, Top 5 compnay market share are about 90%
    This report is a detailed and comprehensive analysis for global Transcatheter Aortic Valve Replacement (TAVR) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Transcatheter Aortic Valve Replacement (TAVR) market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Transcatheter Aortic Valve Replacement (TAVR) market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Transcatheter Aortic Valve Replacement (TAVR) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Transcatheter Aortic Valve Replacement (TAVR) market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Transcatheter Aortic Valve Replacement (TAVR)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Transcatheter Aortic Valve Replacement (TAVR) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Transcatheter Aortic Valve Replacement (TAVR) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Transfemoral Approach
    Transapical Approach
    Others
    Market segment by Application
    Aortic Stenosis
    Aortic Regurgitation
    Others
    Market segment by players, this report covers
    Edwards Lifesciences
    Medtronic
    Abbott
    Boston Scientific
    Meril Life Sciences
    Venus Medtech
    Bracco (HLT)
    JenaValve Technology
    Suzhou Jiecheng Medical Technology Co.
    Peijia Medical
    MicroPort
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Transcatheter Aortic Valve Replacement (TAVR) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Transcatheter Aortic Valve Replacement (TAVR), with revenue, gross margin, and global market share of Transcatheter Aortic Valve Replacement (TAVR) from 2020 to 2025.
    Chapter 3, the Transcatheter Aortic Valve Replacement (TAVR) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Transcatheter Aortic Valve Replacement (TAVR) market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Transcatheter Aortic Valve Replacement (TAVR).
    Chapter 13, to describe Transcatheter Aortic Valve Replacement (TAVR) research findings and conclusion.

    Buy now